Oncology News Today

27/08/2026

📰 NEWS: Clatterbridge project will use cancer data to help improve care for patients

The Clatterbridge Cancer Centre is developing a new project that will bring together valuable information about cancer care, treatment and outcomes to support future research and help improve services for patients.

The project, supported by Civic Health Innovation Labs at the University of Liverpool, will use information that is already collected by the NHS about cancer diagnosis, treatment and patient outcomes. This will be held securely and used by approved researchers to better understand what works best for diverse groups of patients.

Read more:

The Clatterbridge Cancer Centre is developing a new project that will bring together valuable information about cancer care, treatment and outcomes to support future research and help improve services for patients.

25/08/2026

📰 NEWS: Study reveals why DNA damage from smoking and UV rays may cause cancer in some people but not others

Scientists have found the first direct evidence of the powerful role our genetic makeup plays in influencing our risk of cancer, with inherited genes interacting with acquired genetic mutations to shape how tumours evolve.

The findings could explain why some people are more susceptible to cancer than others in the same environment and suggest that future cancer prevention and screening strategies may need to account more carefully for inherited genetics and population diversity.

Read more:

Scientists have found the first direct evidence of the powerful role our genetic makeup plays in influencing our risk of cancer, with inherited genes interacting with acquired genetic mutations to shape how tumours evolve.

24/08/2026

📰 NEWS: Scientists unmask immune cells that supercharge the fight against cancer

A little‑known group of hard-to-find immune cells could help transform cancer treatment, scientists at the University of Manchester’s Cancer Research UK Manchester Institute, have found.

Their discovery, published in the world leading journal Immunity this month, centres on activated dendritic cells, a specialised population of immune cells that orchestrate the body’s attack on cancer.

Read more: https://oncologynewstoday.co.uk/scientists-unmask-immune-cells-that-supercharge-the-fight-against-cancer/

Cell Press Cancer Research UK The University of Manchester Cancer Research UK Manchester Institute EMBO - excellence in life sciences Fondazione AIRC per la Ricerca sul Cancro

A little‑known group of hard-to-find immune cells could help transform cancer treatment, scientists at the University of Manchester’s Cancer Research UK Manchester Institute, have found.

21/08/2026

📰 NEWS: Study urges better support for people with rare spinal cancer

A new study by the Oxford University Hospitals NHS Foundation Trust (OUH) Spinal Sarcoma Service has highlighted the serious emotional and practical challenges faced by people diagnosed with this disease.

The study, published in the open access journal Psycho-Oncology, suggests that people with this rare and complex cancer would benefit from earlier diagnosis, better information, more joined-up aftercare and easier access to psychological support.

The research, carried out in collaboration with the University of Bath, was supported by a £20,000 grant from the Bone Cancer Research Trust (BCRT).

Read more:

A new study by the Oxford University Hospitals (OUH) Spinal Sarcoma Service has highlighted the serious emotional and practical challenges faced by people diagnosed with this disease.

20/08/2026

📰 NEWS: Autoantibodies could play key role in cancer progression and prevention

A research team has suggested that studying immune proteins that target body’s own molecules could lead to new anti-cancer strategies.

Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do.

Pictured: Jean-Laurent Casanova, M.D., Ph.D.

Read more: https://oncologynewstoday.co.uk/autoantibodies-could-play-key-role-in-cancer-progression-and-prevention/

19/08/2026

📰 NEWS: HCA Healthcare UK expands access to CAR T-cell therapy for blood cancer patients at The Christie Private Care

CAR T-cell therapy has already been successfully delivered within HCA Healthcare UK for certain types of blood cancer, including lymphoma and leukaemia, since 2019. In 2025, HCA UK was one of the first to introduce CAR T-cell therapy for multiple myeloma in London, marking a major step forward in treatment options for patients.

This latest development sees this innovative therapy extended to The Christie Private Care in Manchester. Building on HCA UK's long-established provision of advanced cancer care across the UK and expanding access to treatment, with The Christie Private Care becoming the only independent provider outside of London to offer the therapy.

Read more: https://oncologynewstoday.co.uk/hca-healthcare-uk-expands-access-to-car-t-cell-therapy-for-blood-cancer-patients-at-the-christie-private-care/

18/08/2026

📰 NEWS: AI reveals cancer therapy’s effectiveness

Artificial intelligence developed by researchers at University College London (UCL) has revealed a promising combination of cancer treatments that could help patients with locally advanced re**al cancer live longer.

A new study, published in eBioMedicine, showed that combining the cancer treatment irinotecan with standard chemoradiotherapy improves survival against advanced re**al cancer – which has begun to spread to other nearby tissues – in those with a high concentration of cancerous cells in their tumours.

Read more: https://oncologynewstoday.co.uk/ai-reveals-cancer-therapys-effectiveness/

University of Leeds Cancer Research UK UK Research and Innovation

Artificial intelligence developed by researchers at University College London (UCL) has revealed a promising combination of cancer treatments that could help patients with locally advanced re**al cancer live longer.

18/08/2026

📰 NEWS: Newly discovered mechanism behind cancer spread points to potential new target for tackling advanced melanoma

Researchers have uncovered a previously unknown mechanism that helps melanoma cells spread through the body and evade some of the most effective cancer treatments available.

The findings, published in The EMBO Journal, reveal that a protein called nerve growth factor receptor (NGFR) has a central role in both tumour invasion and resistance to immunotherapy. In the longer term, this breakthrough could lead to much-needed new approaches to combat advanced disease.

Read more: https://oncologynewstoday.co.uk/newly-discovered-mechanism-behind-cancer-spread-points-to-potential-new-target-for-tackling-advanced-melanoma/

The Institute of Cancer Research Breast Cancer Now Cancer Research UK Barts Charity Worldwide Cancer Research UK Research and Innovation

Researchers have uncovered a previously unknown mechanism that helps melanoma cells spread through the body and evade some of the most effective cancer treatments available.

14/08/2026

📰 NEWS: Protein lost in lung cancer reveals hidden layer of gene control

The discovery could help explain one of the earliest molecular changes that occurs during the development of lung cancer.

The study, published in Science Advances, reveals that a protein called LIMD1, which is frequently lost in lung cancer, plays a much bigger role in controlling gene activity than scientists previously realised. The findings uncover a previously hidden layer of gene regulation and may provide new insight into how normal cells begin to lose control during the earliest stages of cancer.

Read more: https://lnkd.in/eKV7AXk6

Barts Cancer Institute Queen Mary University of London Cancer Research UK

13/08/2026

📰 NEWS: A patient at Clatterbridge is the first person in the world to be given a pioneering cancer vaccine for the most common type of lung cancer.

Clinicians and researchers at The Clatterbridge Cancer Centre
(CCC) and the University of Liverpool, including the Liverpool Clinical Trials Centre (LCTC), are studying the bespoke vaccine, designed to match the unique genetic changes found in patient Chris Jones’s tumour in this early-stage clinical trial.

Read more:

A patient at Clatterbridge is the first person in the world to be given a pioneering cancer vaccine for the most common type of lung cancer.